Your browser doesn't support javascript.
loading
Bevacizumab-associated osteonecrosis of the femur and tibia.
Oliveira, Leandro J C; Canedo, Felipe S N A; Sacardo, Karina P; Alessi, João V M; Barbosa, Felipe G; Shimada, Andrea K; Katz, Artur.
Afiliação
  • Oliveira LJC; Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Canedo FSNA; Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Sacardo KP; Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Alessi JVM; Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Barbosa FG; Radiology and Nuclear Medicine Service, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Shimada AK; Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Katz A; Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
Oxf Med Case Reports ; 2019(5): omz040, 2019 May.
Article em En | MEDLINE | ID: mdl-31198576
Osteonecrosis is a multifactorial process that can affect different skeletal structures of the body. Osteonecrosis of the jaw associated with bevacizumab, steroids and bisphosphonates, alone or in combination, is a well-documented phenomenon. There are few cases of involvement of the appendicular skeleton. Magnetic resonance imaging is the most sensitive method for diagnosis. We hereby report two cases of osteonecrosis in the right tibia and in bilateral femoral heads in patients with adenocarcinoma of the lung and ovarian papillary serous carcinoma, respectively, that developed the complication after long-term bevacizumab exposure. Long-term exposure to antiangiogenic treatment may be a potential risk factor. Oncologists should be aware that osteonecrosis is a rare but real toxicity associated with bevacizumab and other antiangiogenics, which can occur in locations different from the jaw.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article